1
|
He Y, Karpanen T and Alitalo K: Role of
lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta.
1654:3–12. 2004.PubMed/NCBI
|
2
|
Achen MG, McColl BK and Stacker SA: Focus
on lymphangiogenesis in tumor metastasis. Cancer Cell. 7:121–127.
2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bird-Lieberman EL and Fitzgerald RC: Early
diagnosis of oesophageal cancer. Br J Cancer. 101:1–6. 2009.
View Article : Google Scholar
|
4
|
Karpanen T, Egeblad M, Karkkainen MJ, et
al: Vascular endothelial growth factor C promotes tumor
lymphangiogenesis and intralymphatic tumor growth. Cancer Res.
61:1786–1790. 2001.PubMed/NCBI
|
5
|
Nor JE and Polverini PJ: Role of
endothelial cell survival and death signals in angiogenesis.
Angiogenesis. 3:101–116. 1993. View Article : Google Scholar : PubMed/NCBI
|
6
|
Moldovan NI and Asahara T: Role of blood
mononuclear cells in recanalization and vascularization of thrombi:
past, present, and future. Trends Cardiovasc Med. 13:265–269. 2003.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Blagosklonny MV: Antiangiogenic therapy
and tumor progression. Cancer Cell. 5:13–17. 2004. View Article : Google Scholar
|
8
|
Coultas L, Chawengsaksophak K and Rossant
J: Endothelial cells and VEGF in vascular development. Nature.
438:937–945. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Stoeltzing O, Meric-Bernstam F and Ellis
LM: Intracellular signaling in tumor and endothelial cells: the
expected and, yet again, the unexpected. Cancer Cell. 10:89–91.
2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Breiteneder-Geleff S, Soleiman A, Kowalski
H, et al: Angiosarcomas express mixed endothelial phenotypes of
blood and lymphatic capillaries: podoplanin as a specific marker
for lymphatic endothelium. Am J Pathol. 154:385–394. 1999.
View Article : Google Scholar
|
11
|
Oliver G: Lymphatic vasculature
development. Nat Rev Immunol. 4:35–45. 2004. View Article : Google Scholar
|
12
|
Akishima Y, Ito K, Zhang L, et al:
Immunohistochemical detection of human small lymphatic vessels
under normal and pathological conditions using the LYVE-1 antibody.
Virchows Arch. 444:153–157. 2004. View Article : Google Scholar
|
13
|
Pepper MS and Skobe M: Lymphatic
endothelium: morphological, molecular and functional properties. J
Cell Biol. 163:209–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Fukunaga M: Expression of D2-40 in
lymphatic endothelium of normal tissues and in vascular tumours.
Histopathology. 46:396–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Koukourakis MI, Giatromanolaki A, Sivridis
E, et al: LYVE-1 immunohistochemical assessment of
lymphangiogenesis in endometrial and lung cancer. J Clin Pathol.
58:202–206. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ueda M, Hung YC, Terai Y, et al: Vascular
endothelial growth factor-C expression and invasive phenotype in
ovarian carcinomas. Clin Cancer Res. 11:3225–3232. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Aishima S, Nishihara Y, Iguchi T, et al:
Lymphatic spread is related to VEGF-C expression and D2-40-positive
myofibroblasts in intrahepatic cholangiocarcinoma. Mod Pathol.
21:256–264. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hagendoorn J, Padera TP, Kashiwagi S, et
al: Endothelial nitric oxide synthase regulates microlymphatic flow
via collecting lymphatics. Circ Res. 95:204–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hagendoorn J, Padera TP, Fukumura D and
Jain RK: Molecular regulation of microlymphatic formation and
function: role of nitric oxide. Trends Cardiovasc Med. 15:169–173.
2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Padera TP, Kadambi A, di Tomaso E, et al:
Lymphatic metastasis in the absence of functional intratumor
lymphatics. Science. 296:1883–1886. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Skobe M, Hawighorst T, Jackson DG, et al:
Induction of tumor lymphangiogenesis by VEGF-C promotes breast
cancer metastasis. Nat Med. 7:192–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
22
|
Rubio Bueno P, Naval Gias L, Garcia
Delgado R, et al: Tumor DNA content as a prognostic indicator in
squamous cell carcinoma of the oral cavity and tongue base. Head
Neck. 20:232–239. 1998.
|
23
|
Hida K, Hida Y, Amin DN, et al:
Tumor-associated endothelial cells with cytogenetic abnormalities.
Cancer Res. 64:8249–8255. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hida K, Hida Y and Shindoh M:
Understanding tumor endothelial cell abnormalities to develop ideal
anti-angiogenic therapies. Cancer Sci. 99:459–466. 2008. View Article : Google Scholar : PubMed/NCBI
|
25
|
Akino T, Hida K, Hida Y, et al:
Cytogenetic abnormalities of tumor-associated endothelial cells in
human malignant tumors. Am J Pathol. 175:2657–2667. 2009.
View Article : Google Scholar : PubMed/NCBI
|